Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.

[1]  C. Haglund,et al.  A retrospective analysis of submissions, acceptance rate, open peer review operations, and prepublication bias of the multidisciplinary open access journal Head & Face Medicine , 2006, PLoS biology.

[2]  S. Nordling,et al.  Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. , 1989, British Journal of Cancer.

[3]  C. Wood,et al.  The use of CA‐50 radioimmunoassay inhibition test in the differential diagnosis of benign and malignant liver diseases , 1986, The British journal of surgery.

[4]  N. Habib,et al.  The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. , 1986, British Journal of Cancer.

[5]  C. Haglund,et al.  Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. , 1986, British Journal of Cancer.

[6]  W. Longmire.  Cancer of the pancreas: Palliative operation, Whipple procedure, or total pancreatectomy , 1984, World journal of surgery.

[7]  R. Begent.  The Value of Carcinoembryonic Antigen Measurement in Clinical Practice , 1984, Annals of clinical biochemistry.

[8]  O. Nilsson,et al.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. , 1984, British medical journal.

[9]  O. Nilsson,et al.  Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. , 1983, International archives of allergy and applied immunology.

[10]  D. Carr-Locke.  Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease. , 1980, Gut.

[11]  J. Barkin,et al.  Circulating carcinoembryonic antigen in pancreatic carcinoma , 1978, Cancer.

[12]  H. Hansen,et al.  Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. , 1974, Human pathology.

[13]  R. Blasco,et al.  Tumour markers in gastrointestinal cancers , 1992 .

[14]  H. Haapasalo,et al.  Prognostic factors in human pancreatic cancer, with special reference to quantitative histology. , 1991, Scandinavian journal of gastroenterology.

[15]  P. J. Roberts.  The clinical value of tumour markers. , 1986, Annales chirurgiae et gynaecologiae.